Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Renew

'Mississippi miracle': Kids' reading scores have soared in Deep South states

Mississippi, Alabama and Louisiana have seen a promising turnaround in their student reading scores after passing a series of similar literacy reforms

The Independent UK

MEPs fear EU ethics body will fall short of Von der Leyen’s promises

Commission president had pledged independent body but critics say proposals will not fix self-policing by institutions

The Guardian - UK

EU members agree to nearly double renewable energy by 2030

The European Union reached a deal Thursday to almost double the share of renewables in the 27-nation bloc's energy consumption by 2030. The aim is to achieve carbon neutrality and to stop Russian fossil fuels imports.

Radio France Internationale

From analysis to the latest developments in health,
read the most diverse news in one place.

Want an easy $400 a year? Ditch the gas heater in your home for an electric split system

Earlier this month, regulators flagged power price rises in Queensland, New South Wales, Victoria and South Australia. Like many people, you’re probably wondering how you can minimise the financial pain.

The Conversation

This Year, EVgo Will Renew Hundreds DC Fast Charging Stalls

EVgo, one of the largest EV fast charging networks in the United States, intends to significantly enhance and improve user experience this year.

InsideEVs

The CEO of India’s largest renewables company predicts 'major progress' on climate in the next few years

The Inflation Reduction Act has set off a race between countries to incentivize green investment, says ReNew Power CEO Sumant Sinha.

Fortune

Inside the warehouse where trash from Manchester tips becomes "bargain" treasure - with everything from bikes, furniture, TVs and hoovers for sale

"What we want is for these items to go into good hands, we believe in what we’re trying to achieve here"

Manchester Evening News

Read news from The Economist, FT, and more,
with one subscription

BioCryst's Voluntary Pause Of Rare Blood Disorder Trial Turns Into FDA Clinical Hold

Tucked in its Q1 earnings release, a voluntary pause for BioCryst Pharmaceuticals Inc's (NASDAQ:BCRX) complement-mediated disease therapy has been upgraded to a partial FDA clinical hold. The update clarified why the company paused trials testing BCX9930 in patients with paroxysmal nocturnal hemoglobinuria (PNH), a rare disorder marked by the destruction of red blood cells…

Benzinga

Read Here Why Did BioCryst Stopped Enrollment In BCX9930 Studies In Rare Blood Disorder

BioCryst Pharmaceuticals Inc (NASDAQ:BCRX) has paused enrollment in clinical trials with BCX9930 as the Company investigates elevated serum creatinine levels seen in some patients. The Company will not enroll new patients in the REDEEM-1, REDEEM-2, or RENEW clinical trials during the investigation. Patients currently enrolled in the trials are continuing on the study…

Benzinga

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.